These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 9766559

  • 1. Cancer cells overexpress mRNA of urokinase-type plasminogen activator, its receptor and inhibitors in human non-small-cell lung cancer tissue: analysis by Northern blotting and in situ hybridization.
    Morita S, Sato A, Hayakawa H, Ihara H, Urano T, Takada Y, Takada A.
    Int J Cancer; 1998 Oct 29; 78(3):286-92. PubMed ID: 9766559
    [Abstract] [Full Text] [Related]

  • 2. Differential mRNA expression of urokinase-type plasminogen activator, plasminogen activator receptor and plasminogen activator inhibitor type-2 in normal human endometria and endometrial carcinomas.
    Foca C, Moses EK, Quinn MA, Rice GE.
    Gynecol Oncol; 2000 Nov 29; 79(2):244-50. PubMed ID: 11063652
    [Abstract] [Full Text] [Related]

  • 3. Expression of urokinase plasminogen activator, its receptor and type-1 inhibitor in malignant and benign prostate tissue.
    Usher PA, Thomsen OF, Iversen P, Johnsen M, Brünner N, Høyer-Hansen G, Andreasen P, Danø K, Nielsen BS.
    Int J Cancer; 2005 Mar 01; 113(6):870-80. PubMed ID: 15515049
    [Abstract] [Full Text] [Related]

  • 4. Serine proteinase activation in esophageal cancer.
    Tang WH, Friess H, Kekis PB, Martignoni ME, Fukuda A, Roggo A, Zimmerman A, Büchler MW.
    Anticancer Res; 2001 Mar 01; 21(4A):2249-58. PubMed ID: 11724279
    [Abstract] [Full Text] [Related]

  • 5. Urokinase-mediated posttranscriptional regulation of urokinase-receptor expression in non small cell lung carcinoma.
    Montuori N, Mattiello A, Mancini A, Taglialatela P, Caputi M, Rossi G, Ragno P.
    Int J Cancer; 2003 Jun 20; 105(3):353-60. PubMed ID: 12704669
    [Abstract] [Full Text] [Related]

  • 6. Dedifferentiation of serous ovarian cancer from cystic to solid tumors is associated with increased expression of mRNA for urokinase plasminogen activator (uPA), its receptor (uPAR) and its inhibitor (PAI-1).
    Borgfeldt C, Hansson SR, Gustavsson B, Måsbäck A, Casslén B.
    Int J Cancer; 2001 May 15; 92(4):497-502. PubMed ID: 11304683
    [Abstract] [Full Text] [Related]

  • 7. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
    Hildenbrand R, Schaaf A.
    Int J Oncol; 2009 Jan 15; 34(1):15-23. PubMed ID: 19082473
    [Abstract] [Full Text] [Related]

  • 8. Expression of urokinase-type plasminogen activator, its receptor, and its inhibitor in gastric adenocarcinoma tissues.
    Hong SI, Park IC, Son YS, Lee SH, Kim BG, Lee JI, Lee TW, Kook YH, Min YI, Hong WS.
    J Korean Med Sci; 1996 Feb 15; 11(1):33-7. PubMed ID: 8703368
    [Abstract] [Full Text] [Related]

  • 9. Plasminogen activators and inhibitors are transcribed during early macaque implantation.
    Feng Q, Liu K, Liu YX, Byrne S, Ockleford CD.
    Placenta; 2001 Feb 15; 22(2-3):186-99. PubMed ID: 11170823
    [Abstract] [Full Text] [Related]

  • 10. Expression of urokinase, plasminogen activator inhibitors and urokinase receptor in pregnant rhesus monkey uterus during early placentation.
    Feng Q, Liu Y, Liu K, Byrne S, Liu G, Wang X, Li Z, Ockleford CD.
    Placenta; 2000 Feb 15; 21(2-3):184-93. PubMed ID: 10736241
    [Abstract] [Full Text] [Related]

  • 11. Expression and release of plasminogen activators, their inhibitors and receptor by human tumor cell lines.
    Buø L, Bjørnland K, Karlsrud TS, Kvale D, Kjønniksen I, Fodstad O, Brandtzaeg P, Johansen HT, Aasen AO.
    Anticancer Res; 1994 Feb 15; 14(6B):2445-51. PubMed ID: 7872665
    [Abstract] [Full Text] [Related]

  • 12. Cathepsin B, plasminogenactivator-inhibitor (PAI-1) and plasminogenactivator-receptor (uPAR) are prognostic factors for patients with non-small cell lung cancer.
    Werle B, Kotzsch M, Lah TT, Kos J, Gabrijelcic-Geiger D, Spiess E, Schirren J, Ebert W, Fiehn W, Luther T, Magdolen V, Schmitt M, Harbeck N.
    Anticancer Res; 2004 Feb 15; 24(6):4147-61. PubMed ID: 15736466
    [Abstract] [Full Text] [Related]

  • 13. Differential expression of urokinase-type plasminogen activator, its receptor, and inhibitors in mouse skin after exposure to a tumor-promoting phorbol ester.
    Lund LR, Eriksen J, Ralfkiaer E, Rømer J.
    J Invest Dermatol; 1996 Apr 15; 106(4):622-30. PubMed ID: 8617995
    [Abstract] [Full Text] [Related]

  • 14. Significant down-regulation of the plasminogen activator inhibitor 1 mRNA in pancreatic cancer.
    Warnecke-Eberz U, Prenzel KL, Baldus SE, Metzger R, Dienes HP, Bollschweiler E, Hoelscher AH, Schneider PM.
    Pancreas; 2008 Mar 15; 36(2):173-7. PubMed ID: 18376309
    [Abstract] [Full Text] [Related]

  • 15. Expression of urokinase-type plasminogen activator, its receptor and type-1 plasminogen activator inhibitor is differently regulated by inhibitors of protein synthesis in human cancer cell lines.
    Lund LR.
    FEBS Lett; 1996 Apr 01; 383(3):139-44. PubMed ID: 8925884
    [Abstract] [Full Text] [Related]

  • 16. Differential gene expression of urokinase-type plasminogen activator and its receptor in human renal cell carcinoma.
    Bhuvarahamurthy V, Schroeder J, Kristiansen G, Roigas J, Denkert C, Johannsen M, Lein M, Loening SA, Schnorr D, Jung K, Staack A.
    Oncol Rep; 2005 Sep 01; 14(3):777-82. PubMed ID: 16077991
    [Abstract] [Full Text] [Related]

  • 17. In situ gene expression of urokinase-type plasminogen activator and its receptor in transitional cell carcinoma of the human bladder.
    Bhuvarahamurthy V, Schroeder J, Denkert C, Kristiansen G, Schnorr D, Loening SA, Jung K, Staack A.
    Oncol Rep; 2004 Oct 01; 12(4):909-13. PubMed ID: 15375521
    [Abstract] [Full Text] [Related]

  • 18. In situ localization of mRNA for the fibrinolytic factors uPA, PAI-1 and uPAR in endometriotic and endometrial tissue.
    Bruse C, Radu D, Bergqvist A.
    Mol Hum Reprod; 2004 Mar 01; 10(3):159-66. PubMed ID: 14981142
    [Abstract] [Full Text] [Related]

  • 19. Differential localization and expression of urokinase plasminogen activator (uPA), its receptor (uPAR), and its inhibitor (PAI-1) mRNA and protein in endometrial tissue during the menstrual cycle.
    Nordengren J, Pilka R, Noskova V, Ehinger A, Domanski H, Andersson C, Høyer-Hansen G, Hansson SR, Casslén B.
    Mol Hum Reprod; 2004 Sep 01; 10(9):655-63. PubMed ID: 15243126
    [Abstract] [Full Text] [Related]

  • 20. Renal synthesis of urokinase type-plasminogen activator, its receptor, and plasminogen activator inhibitor-1 in diabetic nephropathy in rats: modulation by angiotensin-converting-enzyme inhibitor.
    Kenichi M, Masanobu M, Takehiko K, Shoko T, Akira F, Katsushige A, Takashi H, Yoshiyuki O, Shigeru K.
    J Lab Clin Med; 2004 Aug 01; 144(2):69-77. PubMed ID: 15322501
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.